-The congenital muscular dystrophies (CMDs) are a group of genetically and clinically heterogeneous hereditary myopathies with preferentially autosomal recessive inheritance, that are characterized by congenital hypotonia, delayed motor development and early onset of progressive muscle weakness associated with dystrophic pattern on muscle biopsy. The clinical course is broadly variable and can comprise the involvement of the brain and eyes. From 1994, a great development in the knowledge of the molecular basis has occurred and the classification of CMDs has to be continuously up dated. In the last number of this journal, we presented the main clinical and diagnostic data concerning the different subtypes of CMD. In this second part of the review, we analyse the main reports from the literature concerning the pathogenesis and the therapeutic perspectives of the most common subtypes of CMD: MDC1A with merosin deficiency, collagen VI related CMDs (Ullrich and Bethlem), CMDs with abnormal glycosylation of alpha-dystroglycan (Fukuyama CMD, Muscleeye-brain disease, Walker Warburg syndrome, MDC1C, MDC1D), and rigid spine syndrome, another much rare subtype of CMDs not related with the dystrophin/glycoproteins/extracellular matrix complex.Key WorDs: congenital muscular dystrophy, MDC1A, collagen VI related disorders, glycosylation of alphadystroglycan, Fukuyama DMC, muscle-eye-brain (MeB) disease, Walker-Warburg syndrome, rigid spine syndrome. distrofia muscular congĂȘnita. parte ii: revisĂŁo da patogĂȘnese e perspectivas terapĂȘuticas resumo -As distrofias musculares congĂȘnitas (DMCs) sĂŁo miopatias hereditĂĄrias geralmente, porĂ©m nĂŁo exclusivamente, de herança autossĂŽmica recessiva, que apresentam grande heterogeneidade genĂ©tica e clĂnica. sĂŁo caracterizadas por hipotonia muscular congĂȘnita, atraso do desenvolvimento motor e fraqueza muscular de inĂcio precoce associada a padrĂŁo distrĂłfico na biĂłpsia muscular. o quadro clĂnico, de gravidade variĂĄvel, pode tambĂ©m incluir anormalidades oculares e do sistema nervoso central. A partir de 1994, os conhecimentos sobre genĂ©tica e biologia molecular das DMCs progrediram rapidamente, sendo a classificação continuamente atualizada. os aspectos clĂnicos e diagnĂłsticos dos principais subtipos de DMC foram apresentados no nĂșmero anterior deste periĂłdico, como primeira parte desta revisĂŁo. Nesta segunda parte apresentaremos os principais mecanismos patogĂȘnicos e as perspectivas terapĂȘuticas dos subtipos mais comuns de DMC: DMC tipo 1A com deficiĂȘncia de merosina, DMCs relacionadas com alteraçÔes do colĂĄgeno VI (Ullrich e Bethlem), e DMCs com anormalidades de glicosilação da alfa-distroglicana (DMC Fukuyama, DMC "Muscle-eye-brain" ou MeB, sĂndrome de Walker Warburg, DMC tipo 1C, DMC tipo 1D). A DMC com espinha rĂgida, mais rara e nĂŁo relacionada com alteraçÔes do complexo distrofina-glicoproteĂnas associadas-matriz extracelular tambĂ©m serĂĄ abordada quanto aos mesmos aspectos patogĂȘnicos e terapĂȘuticos.PAlAVrAs-ChAVes: distrofia muscular congĂȘnita, merosina, colĂĄgeno VI, glicosila...